AMBER MEHTA: Open Payments
NPI 1346716917 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,975 in 102 payments from 14 companies in 2025. Trend: 2023 $1,531 · 2024 $3,701 · 2025 $2,975
Food & beverage: $2,975
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $709 |
| Amgen Inc. | 14 | $612 |
| ABBVIE INC. | 25 | $542 |
| GlaxoSmithKline, LLC. | 6 | $273 |
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| Genentech USA, Inc. | 8 | $164 |
| Mallinckrodt Hospital Products Inc. | 3 | $102 |
| PFIZER INC. | 4 | $78 |
| Janssen Biotech, Inc. | 3 | $78 |
| Sandoz Inc. | 3 | $69 |
Products named: Bimzelx, RINVOQ, BENLYSTA, SKYRIZI, EVENITY, UPLIZNA, KRYSTEXXA, SAPHNELO.
Industry payments across NY — which companies pay providers there.
